| Literature DB >> 31565292 |
Mustapha U Imam1, Maznah Ismail2.
Abstract
Noncommunicable chronic diseases (NCCDs) are the leading causes of morbidity and mortality globally. The mismatch between present day diets and ancestral genome is suggested to contribute to the NCCDs burden, which is promoted by traditional risk factors like unhealthy diets, physical inactivity, alcohol and tobacco. However, epigenetic evidence now suggests that cumulatively inherited epigenetic modifications may have made humans more prone to the effects of present day lifestyle factors. Perinatal starvation was widespread in the 19th century. This together with more recent events like increasing consumption of western and low fiber diets, smoking, harmful use of alcohol, physical inactivity, and environmental pollutants may have programed the human epigenome for higher NCCDs risk. In this review, on the basis of available epigenetic data it is hypothesized that transgenerational effects of lifestyle factors may be contributing to the current global burden of NCCDs. Thus, there is a need to reconsider prevention strategies so that the subsequent generations will not have to pay for our sins and those of our ancestors.Entities:
Keywords: cancer; cardiovascular diseases; epigenetics; global burdens; type 2 diabetes
Year: 2017 PMID: 31565292 PMCID: PMC6607231 DOI: 10.1002/gch2.201700043
Source DB: PubMed Journal: Glob Chall ISSN: 2056-6646
Differences in physical activity dietary consumption between preindustrial and present day humansa)
| Preindustrial humans | Present day humans | |
|---|---|---|
| Physical activity | High | Low |
| Protein | High | Low |
| Carbohydrate | Similar | |
| Refined sugars | Low | High |
| Glycemic load | Low | High |
| Fat | Low | High |
| Saturated fats | Low | High |
| Trans fats | Low | High |
| Monounsaturated fats | High | Low |
| Polyunsaturated fats | High | Low |
| Harmful alcohol use | Low | High |
| Cholesterol | High | Low |
| Fiber | High | Low |
| Sodium/salt | Low | High |
| Calcium | High | Low |
| Ascorbic acid | High | Low |
| Plant based foods including fruits and vegetable | High | Low |
| Grains | Low | High |
Source: Refs. 44, 45, 47, 49.
Epigenetic alterations induced by lifestyle factors that may have shaped human disease history
| Lifestyle factor | Species/study type | Experimental setting [reference] | Epigenetic effects and alterations |
|---|---|---|---|
| Starvation | Human/cohort study | Perinatal and early postnatal exposure to Dutch winter hunger (1944–1945) | Increased offsprings' risk of obesity, diabetes, hypertension, CVD, chronic lung disease, cancers, death, and cognitive and mental disorders in offsprings six decades later |
| Higher risk of insulin resistance and CVD when offsprings are bottle fed instead of breast feeding | |||
| Hypomethylation of lymphocyte IGF2 DMR | |||
| Changes in methylation levels of 181 DMRs of genes involved in growth and metabolism including SMAD7, CDH23, INSR, RFTN1, CPT1A, and KLF13 | |||
| Human/observational case control study | Association of lower weight at birth and higher weight at 18 years with the risk of metabolic syndrome in the general Swedish population at 58 years | Low birth weight and higher catch up growth at 18 years was associated with higher BMI, blood pressure insulin resistance, LDL and triglycerides, and lower HDL at 58 years | |
| Human/cohort study | Association between body size at birth and intake of foods and macronutrients in adulthood in Helsinki birth cohort | Lower birth weights were associated with lower intake of fruits and berries, carbohydrates, sucrose, fructose, and Fibre, and higher intake of fat in adulthood (56–70 years) | |
| Human/cohort study | Risk of insulin resistance and CVD in Indian children with history of low birth weight and obesity at 8 years | Maternal undernutrition resulted in low birth weight, which was associated with increased adiposity at 8 years | |
| Higher risk of insulin resistance and CVD in children who were born small but grew heavy (or tall) afterward | |||
| Human/cohort study | Association between change in parents' and grandparents' early food supply and cardiovascular or diabetes mortality of the grandchildren, among three cohorts born in 1890, 1905 and 1920 in Överkalix parish in northern Sweden up until death or 1995 | Decreased cardiovascular mortality with decreasing availability of food for fathers and paternal grandmothers during slow growth period (9–12 years) | |
| Decreased risk of diabetes with exposure to famine in paternal grandfathers during slow growth period | |||
| Increased diabetes mortality and overall mortality with increased food availability for paternal grandfather during slow growth period | |||
| Increased risk of cardiovascular mortality among females whose paternal grandmothers had sharp change in food supply during their slow growth period from one year to next | |||
| Human/cohort study | Association between mothers' food availability during pregnancy and mortality at 40–70 years among those born between 1805 and 1849 in Skellefteå parish, Sweden | Increased risk of death with famine exposure or overabundance in mothers during the early stages of pregnancy, and food abundance or famine exposure toward the end, respectively | |
| Human/cohort study | Association between maternal undernutrition and risk of adult disease in low and middle income countries (Brazil, Guatemala, India, the Philippines, and South Africa) | Increased risk of shorter adult height, less schooling, reduced economic productivity, and lower offspring birth weight | |
| Higher birth and childhood weights were associated with adult body‐mass index and blood pressure | |||
| Lower birth weight and undernutrition in childhood were associated with high glucose concentrations, blood pressure, and harmful lipid profiles after adjusting for adult BMI and height | |||
| Higher birth weight was associated with poorer lung function and with the incidence of some cancers (breast, prostate, hemopoietic, and colorectal cancers) | |||
| Childhood undernutrition was associated with mental illness, and lower height‐for‐age at 2 years was associated with lower human capital | |||
| Human/cohort study | Association between prenatal undernutrition (including reduced methyl donor availability) and adult mortality in children born in the hungry seasons (June–October) between 1949 and 1994 in the Gambia | Increased methylation levels of metastable epialleles (BOLA3, LOC654433, EXD3, ZFYVE28, RBM46, and ZNF678) in offspring's lymphocytes and hair follicles | |
| Increased risk of premature death among 15–35 year old offsprings | |||
| Human/cross‐sectional study | Association between prenatal malnutrition among Chinese born in 1954–1964 and adult Chronic disease in adolescents and adults | Shorter adult heights and less economic prosperity | |
| Increased risk of metabolic syndrome, schizophrenia and death in both males and females, and increased risk of mental illness in females | |||
| Metabolic risk higher in nutritionally rich environment | |||
| Human | Association between prenatal famine and type 2 diabetes at 40 years of age in those exposed the Ukrainian 1930–1938 famine | Increased risk of type 2 diabetes in both men and women | |
| Human/cohort study | Associations between prenatal exposure to famine during the Nigerian civil war (1967–1970) and hypertension, glucose intolerance, and overweight 40 years after | Increased risk of adult hypertension, insulin resistance, and obesity | |
| Rat | Dietary protein restriction during pregnancy | Increased preference for fatty food than high‐carbohydrate food in male and female rat offsprings at 12 and 30 weeks | |
| Higher plasma insulin in males at 12 weeks | |||
| More gonadal fat in male offsprings at 30 weeks | |||
| Decreased hypothalamic expression of galanin‐2 receptor in female offspring at 12 weeks | |||
| Decreased hepatic expression (mRNA and protein) of sterol response element binding protein (SREBP‐1c), with blunted response after high fat feeding at 12 weeks | |||
| Increased Igf2 and H19 gene expression in the liver of day 0 male offspring | |||
| Hypermethylation of IGF2/H19 DMRs at birth | |||
| Increased expression of Dnmt1 and Dnmt3a, and Mbd2 at birth | |||
| Hypomethylation of the hepatic glucocorticoid receptor (GR) and peroxisome proliferator‐activated receptor alpha (PPARa) gene promoters and increased expression of these genes, and those of acyl‐CoA oxidase and phosphoenolpyruvate carboxykinase in F1 and F2 offsprings | |||
| Mice | Dietary protein restriction during pregnancy | Hypercholesterolemia, hyper‐triacylglycerolemia, hyperglycemia, glucose intolerance, hyperinsulinemia and insulin resistance, increased leptin and resistin, increased adiposity, and leptin resistance characterized by altered expression of neuropeptide Y and proopiomelanocortin (POMC) in F1 and F2 offsprings | |
| Lower body weight/adiposity and higher food intake | |||
| Lower levels of leptin promoter DNA methylation, and fasting mRNA and protein levels, but more pronounced induction postprandially | |||
| Hypermethylation of the hepatic liver X‐receptor alpha promoter with reduced mRNA level of Lxra and its target genes Abcg5/Abcg8 | |||
| Mice | Dietary restriction (50% less diet) during pregnancy | Locus‐specific hypomethylation of sperm DNA at intergenic nonrepetitive regions and CpG islands in F1 adult males, which is lost in F2 offsprings, although locus‐specific gene expression is still altered in tissues including brain and liver | |
| Increased expression of hepatic lipid oxidation genes including PPARα, Pgc1α and Pgc1β, and downregulation of genes involved in lipid synthesis including Scd1, Srebp1, and Dgat1 | |||
| Widespread changes in placental miRNAs and DNA methylation patterns of genes associated with immunological, metabolic, gastrointestinal, cardiovascular, and neurological chronic diseases, as well as those involved in transplacental nutrient transfer and fetal development | |||
| High fat diet/obesity | Human/cohort study | Parental high obesity | Paternal obesity associated with decreased methylation levels at the IGF2, MEST, PEG3, and NNAT DMRs in cord blood |
| Paternal obesity associated with decreased methylation levels at the MEG3, NDN, SNRPN, and SGCE/PEG10 DMRs, and higher methylation levels of MEG3‐IG and H19 DMRs in sperm | |||
| Maternal obesity associated with increased methylation of PLAGL1 DMR and decreased MEG3 DMR in cord blood | |||
| Human/cohort study | Childhood obesity | Increased DNA methylation of the CASP10, CDKN1C, EPHA1, HLADOB3, IRF5, MMP9, MPL, NID1, retinoid X receptor‐α, IGF2/H19, and POMC, and lower methylation of LINE1 in children are strongly associated with childhood obesity | |
| Hypo‐ and hypermethylation and gene expression changes of the TACSTD2 gene at birth associated with childhood obesity | |||
| Rat | Maternal high fat diet prior to, and during pregnancy and lactation | Higher placental weight, birth weight, and blood glucose at birth | |
| Increased weight gain, insulin resistance, lipid profiles, GLP‐1, serum leptin, and fat preference | |||
| Inhibited osteogenesis and decreased expression of bone homeodomain‐containing factor A10 (HoxA10), osteocalcin, alkaline phosphatase, Runx, and osterix and increased expression of fatty acid binding protein and PPARγ | |||
| Hypermethylation of bone HoxA10 promoter | |||
| Higher phosphorylated 4EBP1 (T37/46 and S65) and rpS6 (S235/236) in the placenta | |||
| Lower phosphorylation of AMPK and eIF2alpha in the placenta | |||
| Hypomethylation of PPARγ, FAS, adiponectin and leptin gene promoter in white adipose, with consequently increased expression (mRNA) of PPARγ, FAS, and adiponectin, and decreased leptin expression | |||
| Decreased hepatic expression of Wnt1 (mRNA) and nuclear β‐catenin (protein) | |||
| Decreased hepatic mRNA expression of circadian (CLOCK, BMAL1, REV‐ERBα, CRY, PER) and metabolic (PPARα, SIRT1) genes | |||
| Differential expression of H3K4me3 and H3K27me3 in hepatic PPARα promoter | |||
| Decreased hepatic Wnt1 gene promoter H4 and H3 acetylation and increased H3K9 methylation | |||
| Increased hepatic expression (mRNA) of gluconeogenic genes (PEPCK1, G8Pase, Cebpα, Cebpβ, Srebp‐1a, and Pgc1a) | |||
| Decreased H3Ac, H3K4me2, H3K9me3, and H3K27me3 in hepatic PEPCK1 promoter | |||
| Increased H4Ac and H3K4me2 in hepatic PEPCK1 coding and upstream regions, and reduced H3K9me3 in hepatic PEPCK1 coding region | |||
| Increased hepatic TBARs, and expression (mRNA) of p16INK4a and Cox2 | |||
| Increased expression (mRNA) of hepatic lipogenesis, oxidative stress, and inflammatory genes | |||
| Decreased hepatic expression (mRNA) of Pon1, Pon2, Pon3, and Sod1, Gpx1 | |||
| Increased H4Ac and H3K4me2 in hepatic Pon1 promoter | |||
| Increased hepatic mRNA levels of peroxisome proliferator activated receptor‐alpha, carnitine palmitoyl transferase‐1a and Igf2 | |||
| Decreased expression of ≈23 hepatic miRNA levels (≈1.5–4.9‐fold) including miR‐709, miR‐122, miR‐192, miR‐194, miR‐26a, let‐7a, let‐7b, and let‐7c, miR‐494 and miR‐483 | |||
| Increased expression (mRNA) of hepatic Cdkn1a | |||
| Increased expression (mRNA) of DAT and MOR in the brain | |||
| Decreased expression (mRNA) of hypothalamic NPY, proopiomelanocortin, leptin receptor and STAT3 | |||
| Global hypomethylation in prefrontal cortex | |||
| Increased expression of orexigenic peptides, galanin, enkephalin, and dynorphin, in the paraventricular nucleus and orexin and melanin‐concentrating hormone in the perifornical lateral hypothalamus | |||
| Decreased expression (mRNA) of Pgc‐1α and its target genes (Glut4, Cox4, and Cyt c) in skeletal muscle | |||
| Hypermethylation of the skeletal muscle Pgc‐1α and hypothalamic POMC promoters | |||
| Rat | Maternal low protein diet prior to, and during pregnancy and lactation, and postnatal high fat diet | Increased adipose growth rate, insulin resistance and IGF2 mRNA and methylation | |
| mice | Paternal high fat diet | Impaired glucose tolerance | |
| Altered expression of 642 pancreatic islet genes involved in calcium‐, MAPK‐ and Wnt‐signaling pathways, apoptosis and the cell cycle | |||
| Hypomethylation of the pancreatic | |||
| Global hypomethylation of germ cell DNA in F0 mice | |||
| Altered testes mRNA (414 genes involved in nitric oxide and ROS pathways, Sertoli cell junction signaling, EIF2 signaling, NF‐ | |||
| Mice | High fat diet during pregnancy and lactation | Increased body weight, body fat content, inflammatory markers and serum insulin and leptin concentrations | |
| Decreased adiponectin expression and increased leptin in white adipose tissue | |||
| Lower H3K9Ac and higher H3K9me2 in adiponectin promoter of white adipose tissue | |||
| Increased CD‐68, chemokine receptor‐2 and TNFa mRNA, and decreased GLUT‐4 mRNA in subcutaneous adipose tissue | |||
| Higher H4K20me at leptin promoter of white adipose tissue | |||
| Increased hepatic expression (mRNA) of PEPCK, PGC1α, JNK, and Ikbkb | |||
| Increased hepatic H3K14ac and H3K9me3 | |||
| Decreased hepatic global histone methylation and H3K9Me2 in F2 mice | |||
| Decreased expression of hepatic miR‐122 and increased expression of miR‐370 | |||
| Decreased Histone methylation in promoters of hepatic LXRa and ERO1‐a in F2 mice | |||
| Upregulation of hypothalamic toll‐like receptor (Tlr) 4 signaling cascade including c‐Jun N‐terminal kinase 1 and IκB kinase‐β inflammatory pathways | |||
| Increased expression (mRNA) of DAT in the ventral tegmental area, nucleus accumbens, and prefrontal cortex and in the hypothalamus | |||
| Increased expression (mRNA) of MOR and PENK in nucleus accumbens, prefrontal cortex, and hypothalamus | |||
| Global and gene‐specific (DAT, MOR, and PENK) promoter DNA hypomethylation in the brain | |||
| Increased H3K9me and decreased H3Ac in the MOR promoter region of the brain | |||
| Global DNA hypomethylation in female placenta | |||
| Differential methylation of placental Igf2r regions that serve as binding sites for important transcription factors including Pax4, Smarca3, Vbp, Pax6, Yy1, Oct1, Nrf2/Arp, Ppar/Rxr, Egr3, Rxr, Mzf1, Sry/Sox9, Gcm1, Stat6, Nudr/Deaf‐1, and altered expression of placental metabolism genes including Dio3, Rtl1, Dlk1, Slc22a1, Slc22a2, Slc22a3 especially in the female placenta | |||
| Hypermethylation of the leptin promoter in F0 oocytes and female F1 livers, and increased hepatic expression (mRNA) | |||
| Hypomethylation of the Ppar‐α promoter in F0 oocytes and F1 female livers, and decreased hepatic expression (mRNA) | |||
| Hypermethylation level of Ppar‐α promoter in F1 oocyte | |||
| Mice | High fat diet during pregnancy and lactation in successive generations (F0–F2) | Increased body weight in female mice in F1 and F2 generations (most severe in F2) | |
| Increased macrophage infiltration and inflammatory gene expression in adipose tissue | |||
| Hypomethylation of the adipose tissue promoters of Tlr1, Tlr2, and linker for activation of T cells | |||
| Mice | Embryonic | Increased penetrance of cited2‐induced defects including cardiac malformation, adrenal agenesis, and other defects | |
| Decreased expression (mRNA) of Pitx2c in Cited2‐deficient embryos | |||
| Macaque | Maternal high fat diet | Increased hepatic Npas2 | |
| Increased H3K14ac in Npas2 promoter | |||
| Increased hepatic GCN5 (mRNA), global H3K14ac and decreased HDAC III (mRNA) and SIRT1 (mRNA, protein and activity) expression | |||
| Increased expression of downstream hepatic genes modulated by SIRT1 including PPARΑ, PPARG, SREBF1, CYP7A1, FASN, and SCD | |||
| Increased H3K14ac and DBC1‐SIRT1 complex in fetal livers | |||
| Increased hypothalamic POMC mRNA expression, and decreased agouti‐related protein mRNA and peptide levels | |||
| Increased hypothalamic proinflammatory cytokines, including IL‐1β and IL‐1 type 1 receptor | |||
| White rice | Rat | Maternal white rice consumption for 8 weeks before and throughout gestation and lactation | Worsened glucose tolerance |
| Reduced serum adiponectin levels, and increased weights, homeostatic model assessment of insulin resistance, serum retinol binding protein‐4 levels, and leptin levels | |||
| Altered expression of insulin signaling genes in the liver, muscle, and adipose tissues | |||
| Exercise/weight loss | Human/cohort study | Three to six month exercise in men | Differential methylation of 7663 genes, including 18 obesity‐related genes |
| Global and genome‐wide sperm DNA methylation changes in genes related to diseases like schizophrenia and Parkinson's disease | |||
| Human/cohort study | Differences in methylation levels among children born to the same women before and after weight loss due to bariatric surgery | Lower birth weight, and decreased childhood obesity, insulin resistance, cholesterol, leptin and CRP in offsprings born after weight loss | |
| Differential methylation and changes in expression of 5698 genes involved in glucoregulatory, inflammatory, and vascular disease pathways in offsprings born after weight loss | |||
| Differential methylation of 23 449 genes (HLA‐DQA1, HLA‐DQB1, and TSPAN18 were most significant), and changes in expression of 3074 genes, involved with insulin receptor signaling, type 2 diabetes signaling, and leptin signaling in obesity in offsprings born after weight loss | |||
| Rat | Maternal high fat diet + exercise during pregnancy and lactation | Attenuation of high fat diet‐induced decreases in expression of Pgc‐1α and its target genes (Glut4, Cox4, and Cyt c) in skeletal muscle | |
| Smoking | Human/cohort study | Long term epigenetic effects of smoking | Long term lymphocyte DNA methylation changes in over 2600 CpG sites annotated to 1405 genes affecting pulmonary function, and risks of cancers, inflammatory diseases and heart disease, which lasted over 30 years; quitting reversed some of these effects within five years |
| Human/cohort study | Association between paternal smoking around the slow growth period and epigenetic changes in children in the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort | Higher male offsprings BMIs by age 9 | |
| Human/cohort study | Association between maternal smoking and infant blood methylation | Altered methylation of 185 CpGs of 110 genes, including FRMD4A, ATP9A, GALNT2, and MEG3, implicated in processes related to nicotine dependence, smoking cessation, and placental and embryonic development | |
| Human/cohort study | Association between maternal smoking and methylation changes in children from kindergarten and first graders | Lower methylation of AluYb8 | |
| Lower LINE1 methylation in children with the GSTM1‐null genotype | |||
| Higher methylation in children with the GSTM1‐present genotype | |||
| Differential methylation of CpG loci in eight genes; two validated genes showed increased methylation | |||
| Human/cohort study | Association between grandmother's, mother's (before or during pregnancy using cotinine measured at 18 weeks gestation), and father's (before conception) smoking history, and methylation at these 26 CpGs mapped to 10 genes (GFl1, AHRR, HLA‐DPB2, MYO1G, ENSG00000225718, CNTNAP2, EXT1, TTC7B, CYP1A1 and RUNX1) in the Norwegian Mother and Child Cohort Study | Differential methylation changes only when mother continued smoking during pregnancy past gestational week 18 | |
| Human/cohort study | Association between maternal smoking and placental and cord blood methylation | Fetal growth restriction | |
| Decreased global DNA methylation | |||
| Altered methylation patterns within the P2 promoter of | |||
| Higher methylation at the IGF2 DMR | |||
| Increased CYP1A1 expression | |||
| Hypomethylation of CpG sites on CYP1A1 promoter immediately proximal to the 5′‐xenobiotic response element transcription factor binding element | |||
| Altered expression of 623 genes and the methylation of 1024 CpG dinucleotides | |||
| Differential methylation of 23 CpGs mapped to eight genes: AHRR, GFI1, MYO1G, CYP1A1, NEUROG1, CNTNAP2, FRMD4A, and LRP5 | |||
| Downregulation of placental miR‐16, miR‐21, and miR‐146a | |||
| Rat | Association between maternal nicotine exposure and asthma | Increased asthma risk in F2 offsprings | |
| Decreased lung PPARγ expression (mRNA) | |||
| Increased H3 Acetylation and decreased H4 acetylation in the lung | |||
| Increased DNA methylation, and H3 and H4 acetylation in testis | |||
| Decreased DNA methylation and increased H4 acetylation in the ovary | |||
| Alcohol | Human/cohort study | Association between maternal alcohol and DNA methylation in whole blood/buccal tissues of children (1–16 years) | Hypomethylation of the KvDMR1 and PEG3 DMR |
| Differential methylation of 269 CpGs on multiple genes related to protocadherins, glutamatergic synapses, and hippocampal signaling | |||
| Human/cohort study | Association between periconceptional alcohol use in parents and cord blood methylation levels | Hypomethylation of the DAT gene promoter due to maternal (before and during pregnancy) and paternal (before conception) alcohol use | |
| Hypomethylation of the SERT gene promoter due to maternal (before and during pregnancy) alcohol use | |||
| Hypermethylation of the MeCP2 promoter due to due to maternal (during pregnancy) alcohol use | |||
| Mice | Maternal alcohol exposure in early gestation | Decreased embryonic IGF2 promoter methylation and IGF 2 expression | |
| Decreased prenatal growth | |||
| Increased mortality, and digit and vertebral malformations | |||
| Increased miR‐467b‐5p in Slc17a6 promoter resulting in hypomethylation of hippocampal H3K4me3 at the Slc17a6 promoter, with corresponding increased mRNA levels of hippocampal Slc17a6, although its protein product VGLUT2 was decreased | |||
| Rat | Maternal ethanol exposure during pregnancy | Behavioral, learning and memory deficits, and decreased birth and brain weights, and incisor emergence | |
| Higher plasma methionine and prolactin concentrations | |||
| Higher pituitary weight, pituitary prolactin protein and mRNA | |||
| Lower pituitary levels of dopamine D2 receptor (D2R) mRNA and protein, and hypermethylation of the pituitary D2R promoter | |||
| Increased pituitary mRNA levels of DNA methylating genes (DNMT1, DNMT3b, MeCP2) and histone modifying genes (HDAC2, HDAC4, G9a) | |||
| Lower whole brain Mtr and Mat2a mRNA, hippocampal Mtr and Cbs mRNA in males | |||
| Higher hippocampal Mtr, Mat2a, Mthfr, and Cbs mRNA in females | |||
| Lower hippocampal Nr3c1 mRNA and NGFI‐A protein in females | |||
| Higher hypothalamic Slc6a4 mean promoter methylation with corresponding lower hippocampal Slc6a4 mRNA in males | |||
| Lower hypothalamic Set7/9, phosphorylated H3S10, and β‐EP, proteins | |||
| Higher hypothalamic G9a, Setdb1, and MeCP2 proteins | |||
| Lower hypothalamic H3K4me3, acetylated H3K9, and POMC mRNA in F1 male and female offspring, and F2 and F3 male offsprings | |||
| Higher hypothalamic H3K9me2, Dnmt1 and POMC promoter methylation in F1 male and female offspring, and F2 and F3 male offsprings | |||
| Hypermethylation of sperm POMC in F1–F3 | |||
| Chemicals/environmental pollutants | Human/cohort study | BPA exposure in men | Hypomethylation of the sperm LINE‐1 gene |
| Human/cohort study | Maternal exposure to organophosphate pesticides and persistent organic pollutants | Decreased adiponectin levels with increasing levels of cord blood | |
| Decreased insulin levels with increasing levels of cord blood DDE and polychlorinated biphenyl congener 153 (PCB153) in female offsprings | |||
| Increased insulin levels with increasing levels of maternal urinary Dialkylphosphate (DAP) in female offspring | |||
| Human/cohort study | Association between prenatal prenatal organochlorine compound (OC) concentrations [polychlorinated biphenyls (PCBs), dichlorodiphenyldichloroethylene (DDE), and dichlorodiphenyltrichloroethane (DDT)] and overweight at 6.5 years | Overweight was associated with prenatal PCB and DDE exposure in boys and girls, but with DDT only in boys | |
| Rat | Maternal dichlorodiphenyltrichloroethane (DDT) exposure during pregnancy | Kidney, prostate and ovary abnormalities in F1 and F3 adults, and mammary tumor development in F1 | |
| Obesity in F3 adults, transmitted via female (egg) and male (sperm) germlines | |||
| Differential methylation changes in multiple sperm DMRs of F3 generation, including those of obesity‐related genes | |||
| Rat | Maternal exposure to Plastics Derived Endocrine Disruptors (BPA, DEHP, and DBP) during pregnancy | Increased kidney and prostate disease | |
| Hypomethylation in sperm Gck promoter | |||
| Reduced testicular size, and serum and testicular testosterone levels in males | |||
| Increased testicular GnRH mRNA and decreased testicular StAR and P450scc mRNA | |||
| Decreased H3 and H3K14 acetylation in the promoter of StAR | |||
| Increased pubertal abnormalities, testis disease, obesity, and ovarian disease (primary ovarian insufficiency and polycystic ovaries) in F3 generation | |||
| Glucose intolerance and insulin resistance in F2 generation | |||
| Downregulation of Gck mRNA, hypermethylation of the hepatic Gck promoter of F2 liver | |||
| Differential methylation of 197 DMRs in gene promoters in F3 sperm epigenome | |||
| Rat | Maternal vinclozolin exposure during pregnancy | Increased blood lipid, prostate, kidney, immune system and testis abnormalities, and mammary tumor development in F1 to F4 generations (e.g., breast) | |
| Rat | Maternal Dioxin (TCDD) exposure during pregnancy | Increased prostate disease, ovarian primordial follicle loss and polycystic ovary disease | |
| Increased kidney disease in males, pubertal abnormalities in females, ovarian primordial follicle loss and polycystic ovary disease in F3 generation | |||
| Differential methylation of 50 DMRs in sperm gene promoters of F3 generation | |||
| Rat | Maternal exposure to permethrin and DEET (pesticide and insect repellent mixture) during pregnancy | Increased pubertal abnormalities, testis disease, and ovarian disease (primordial follicle loss and polycystic ovarian disease) in F3 generation | |
| Differential methylation of 363 DMRs in sperm gene promoters in F3 generation | |||
| Rat | Maternal exposure to methoxyclhor during pregnancy | Increased kidney disease, ovary disease, and obesity in F1 and the F3 generations | |
| Differential methylation of genome‐wide DMRs in sperm gene promoters of F3 generation | |||
| Rat | Maternal exposure to jet fuel JP‐8 hydrocarbon during pregnancy | Increased primordial follicle loss and kidney, prostate, pubertal and polycystic ovarian abnormalities | |
| Increased obesity, primordial follicle loss and polycystic ovarian disease in F3 generations | |||
| Differential methylation of 33 DMRs in sperm gene promoters in F3 generation | |||
| Mice | Maternal exposure to tyibutyltin during pregnancy | Increased white adipose tissue depot weights, adipocyte size, and adipocyte number in F1 to F3 generations | |
| z | Increased reprogramming of multipotent mesenchymal stem cells toward the adipocyte lineage at the expense of bone in F1 to F3 generations | ||
| Upregulation of hepatic genes involved in lipid storage/transport (Fsp27 and FATP), lipogenesis (PPARγ2, SREBP1c, GyK, and FASN), and lipolysis (PPARα and ACOX) with consequently increased hepatic lipid accumulation F1 to F3 generations | |||
| Zebrafish | Maternal BPA exposure during pregnancy | Decreased reproductive performance in F1–F3 females | |
| Increased heart failure rates and downregulation of 5 genes (myh6, cmlc2, atp2a2b, sox2, and insrb) genes involved in cardiac development in F1 and F2 |
Effects and/or alterations are those reported in F1 generation due to exposure in F0 in comparison to the control group without the exposure, except otherwise stated. BMI: body mass index; CVD: cardiovascular disease; DMR: differentially methylated region; HDL: high density lipoprotein; LDL: low density lipoprotein; ROS: reactive oxygen species.
Epigenetic alterations due to methyl donors and other micronutrients in humans and animal experimentation
| Nutrient | Specie | Experimental setting [reference] | Physiological changes/epigenetic implications |
|---|---|---|---|
| Methyl donors including folic acid, methionine, choline, betaine, vitamin B | Human | Cross sectional study of the relationship between maternal and cord blood folate and vitamin B12 levels and methylation of IGF2 | Higher methylation in IGF2 P3 in maternal blood than in cord blood, and higher IGF2 P2 methylation in cord blood than in maternal blood. P2 and P3 methylation correlated with serum levels of vitamin B12 in mother's blood, but not in cord blood |
| P2 methylation correlated with mother's smoking history and weight gain during pregnancy | |||
| Human | Survey of folic acid intake before and during pregnancy using self‐administered questionnaire, and association with methylation levels of IGF2/H19 DMRs in cord blood | Decreased methylation levels at the H19 DMR with increasing folic acid intake before and during pregnancy | |
| More pronounced changes in males offsprings | |||
| Human | Associations of maternal vitamin B12, betaine, choline, folate, cadmium, zinc and iron periconceptionally and during the second trimester, and Long Interspersed Nuclear Element‐1 (LINE‐1) methylation levels | Higher cord blood methylation in male than female infants | |
| Higher maternal cadmium was associated with increased maternal blood first trimester LINE‐1 methylation, and decreased cord blood LINE‐1 methylation | |||
| Increased betaine intake induced lower cord blood LINE‐1 methylation levels | |||
| Increased periconceptional choline decreased cord blood LINE‐1 methylation only in male offsprings | |||
| Human | Associations between periconceptional folic acid use and IGF2 methylation in 17 month old offsprings | Higher maternal S‐adenosylmethionine blood levels, increased IGF2 methylation and lower birth weight with folic acid use | |
| Mice | Folic acid supplementation (0.4 and 2 mg kg−1 diet) before mating and during pregnancy | Hypomethylation of fetal gut Slc394a | |
| Mice | Maternal choline [high (4.95 g kg−1), control (1 g kg−1) and low (0 g kg−1) of choline in diet) supplementation from day 12 to 17 of pregnancy | Decreased proliferation of endothelial cells (EC) and number of blood of blood vessels by 25%–32%, with increased EC differentiation by 25% in the control hippocampus compared with the choline supplemented groups | |
| Increased expression of angiogenic genes (Vegfc | |||
| Hypomethylation of the CpG islands in promoter of Vegfc and Angpt2 in choline deficient group compared with control | |||
| Decreased monomethyl‐lysine 9 of H3 (H3K9me1) in the ventricular and subventricular zones (25%), and dimethyl‐lysine 9 of H3 (H3K9me2) in the pyramidal layer (37%) of hippocampus of choline deficient group | |||
| Reduced expression (80%) of hippocampal G9a histone methyltransferase in choline deficient group | |||
| Hypomethylation of H3 upstream of the RE1 binding site in the calbindin 1 promoter | |||
| Hypermethylation of a CpG site within the calbindin1 promoter. Decreased binding of REST to RE1, which recruits G9a by 45%, with consequent increase in expression of calbindin 1 in choline deficient group | |||
| Mice | Maternal folic acid, vitamin B12, betaine and choline supplementation from day for 8 weeks prior to, and throughout pregnancy and lactation | Increased DNA methylation at the viable yellow agouti (A(vy)) and Axin (Fu) metastable epialleles | |
| Dampened transgenerational transmission of obesity | |||
| Rat | Maternal choline [high (4.95 g kg−1), control (1 g kg−1) and low (0 g kg−1) of choline in diet) supplementation from day 12 to 17 of pregnancy | Improved age‐related memory in choline supplemented group | |
| Increased S‐Adenosylmethionine levels in fetal liver and brain of choline supplemented group | |||
| Increased IGF2 and IGF2R mRNA and protein and acetylcholine release from the frontal cortex and hippocampus of choline supplemented group | |||
| Increased expression of calcium/calmodulin (CaM)‐dependent protein kinase (CaMK) I in the cortex and transcription factor Zif268/EGR1 in the cortex and hippocampus, and reduced expression of CaMKIIbeta, protein kinase Cbeta2, and GABA(B) receptor 1 isoforms c and d in the hippocampus | |||
| Increased global DNA methylation and overexpression of Dnmt1 mRNA in liver and brain of choline deficient group | |||
| Hypermethylation of Igf2 DMR, increased hepatic Igf2 mRNA levels and hypomethylation of a CpG site within the Dnmt1 locus in fetal liver of the choline deficient group | |||
| Decreased brain and liver Dnmt3a and methyl CpG‐binding domain 2 (Mbd2) protein, and cerebral Dnmt3l in the choline deficient group | |||
| Increased DNA methylation of the G9a and Suv39h1 genes, and with consequent decreases in mRNA and protein expression of G9a and Suv39h1 histone methyltransferases | |||
| Decreased H3K9Me2 and H3K27Me3, and increased H3K4Me2 in choline‐deficient group | |||
| Reduced tumor growth rate in 7,12‐dimethylbenz[alpha]anthracene induced mammary tumors in choline supplemented group | |||
| Increased expression of genes that confer favorable breast cancer outcomes (Klf6, Klf9, Nid2, Ntn4, Per1, and Txnip) and decreased expression of those associated with aggressive disease (Bcar3, Cldn12, Csf1, Jag1, Lgals3, Lypd3, Nme1, Ptges2, Ptgs1, and Smarcb1) in choline supplemented group | |||
| Increased DNA methylation of the tumor suppressor gene, stratifin, with corresponding decrease in expression of its mRNA and protein in mammary tissue of choline supplemented group | |||
| Rat | Prenatal exposure to low (0.59 mmol−1 kg d−1) or high (3.46 mmol−1 kg d−1) choline on days 11–18 of pregnancy | Offsprings of choline supplemented group had increased levels of hippocampal BDNF, NGF, and IGF‐1. Choline supplementation also caused less seizure‐induced hippocampal neurodegeneration, dentate cell proliferation, hippocampal GFAP mRNA expression levels, prevented the loss of hippocampal GAD65 protein and mRNA expression, and altered growth factor expression patterns | |
| Rat | Third trimester ethanol (5.25–6 g kg−1 d−1) exposure with or without choline supplementation (100–250 mg kg−1 d−1) | Choline supplementation enhanced offsprings' ethanol induced learning and memory deficits | |
| Choline attenuated alcohol induced decreases in birth and brain weight, incisor emergence, and behavioral deficits | |||
| Choline supplementation attenuated ethanol‐induced suppression of hypothalamic H3K4me3, Set7/9, acetylated H3K9, phosphorylated H3S10, β‐EP, and POMC mRNA, and increases in H3K9me2, G9a, Setdb1, Dnmt1, MeCP2, POMC gene methylation | |||
| Piglet | Betaine supplementation during pregnancy (3 g kg−1 diet) compared with control (no betaine) | Betaine supplementation increased serum and hepatic betaine contents, and expression of hepatic methionine metabolic enzymes | |
| Increased serum concentrations of lactic acid and glucogenic amino acids, including serine, glutamate, methionine and histidine | |||
| Increased hepatic glycogen content, PEPCK1 enzyme activity, protein expression of gluconeogenic enzymes (pyruvate carboxylase, phosphoenolpyruvate carboxykinase 1 and 2, and fructose‐1, 6‐bisphosphatase) | |||
| Reduced hepatic expression of cell cycle regulatory genes, cyclin D2 (CCND2) and presenilin1 (PSEN1) | |||
| Reduced hepatic expression of STAT3, phosphorylation at Tyr705 and Ser727 residues, and STAT3 binding to the CCND2 and PSEN1 promoters | |||
| Reduced STAT3 upstream kinases (phospho‐ERK1/2, phospho‐SRC and phospho‐JAK2) | |||
| STAT3 DNA hypermethylation, and increased H3K27me3, EZH2 and miR‐124a expression, and H3K27me3 on STAT3 promoter | |||
| Increased hippocampal expression of IGF2 and its receptors IGF1R and IGF2R, and the downstream extracellular signal‐regulated kinase 1/2. Hypermethylation of the IGF2 DMRs in the hippocampus of betaine group | |||
| DNA hypermethylation and increased H3K27me3 in the promoter of PEPCK1 | |||
| DNA hypomethylation and increased H3K4me3 in promoters of PEPCK2 and FBP1 | |||
| Decreased expression of two miRNAs (miRNA 184 and miRNA 196b) targeting pyruvate carboxylase and 6 miRNAs (miRNA‐140‐3p, miRNA‐424‐3p, miRNA‐196b, miRNA‐370, miRNA‐30b‐3p and miRNA‐92b‐5p) targeting PEPCK1 in the liver | |||
| Rat | Dietary protein restriction (90 g kg−1 protein) with folic acid supplementation (1 or 3 mg kg−1) during pregnancy in rats | Folic acid attenuated low protein‐induced increases in Igf2, H19, Dnmt1 and Dnmt3a, and Mbd2 expression in the liver of male offsprings, and hypermethylation of IGF2/H19 DMRs | |
| Rat | Maternal high fat diet during pregnancy and lactation with or without methyl donors (15 g Choline Chloride, 15 g Betaine, 15 mg Folic acid, 1.5 mg Vitamin B12, 7.5 g | Methyl donors attenuated high fat diet induced increases in weight gain and fat preference in offsprings | |
| Attenuated increases in DAT mRNA and MOR mRNA in male and female brain, and global hypomethylation in prefrontal cortex | |||
| Rat | Maternal high fat diet during pregnancy and lactation with or without methyl donors (18 mg folic acid, 1.5 mg vitamin B12, 18 g choline, 7.5 mg | Methyl donors attenuated high fat diet induced offspring excess weight gain, increased adiposity, insulin resistance, lipid profiles, GLP‐1 and leptin | |
| Reduced high fat diet induced expression of PPARγ, FAS and adiponectin genes, and enhanced expression of high fat diet induced leptin gene suppression in white adipose | |||
| Increased high fat diet induced hypomethylation of PPARγ, FAS, adiponectin and leptin gene promoter in white adipose | |||
| Rat | Vitamin A (4 IU vitamin A g−1 diet) supplementation against diet without vitamin A for 10 weeks prior to, and during pregnancy until gestational day 13 | Higher cardiac defects in vitamin A‐deficient group | |
| Higher methylation of GATA‐4 gene and lower expression of GATA‐4 mRNA in embryos of vitamin A‐deficient group | |||
| Upregulation of DNMT1 and downregulation of DNMT3a and DNMT3b expression | |||
| Cadmium/iron | Human | Association between maternal iron, zinc and cadmium and offsprings' birth weight and DNA methylation | Increased maternal blood cadmium levels were associated with lower birth weight, and lower offspring methylation at the MEG3 DMR and PEG3 DMR in males and females respectively |
| Lower maternal iron and zinc potentiated the cadmium‐induced hypomethylation of on PEG3 and PLAGL1 DNA | |||
| Iron | Rat | iron‐restricted diet (3–10 mg kg−1 Fe compared with 225 mg kg−1 Fe) given to rats 2 weeks prior to and throughout pregnancy + postnatal high fat diet | 15% reduction in birth weight |
| Severe anemia at birth | |||
| Higher consumption of high fat diet | |||
| Reduced locomotor activity | |||
| Higher obesity rate | |||
| Increased tendency for salt sensitivity and hypertension | |||
| Rat | Iron restriction in drinking water (3 mg L−1 ferrous sulfate compared with 250 mg L−1) given to pregnant rats | Higher adipose tissue mass | |
| Increased serum | |||
| glucose, insulin, triglyceride, leptin, TNFα and IL6 concentrations | |||
| Increased oxidative stress | |||
| Rats | Iron deficient diet (4 mg kg−1 Fe) from gestational day 2 through postnatal day 7, and thereafter iron‐sufficient diet (200 mg kg−1 Fe), with or without choline supplementation (5 g kg−1) from gestational day 11 to 18 | Iron deficiency induced memory impairments, and suppression of BDNF‐III and ‐IV mRNAs and BDNF protein, 3‐hydroxy‐3‐methylglutaryl CoA reductase, c‐fos, and early growth response gene 1 and 2 | |
| Iron deficiency suppressed hippocampal expressions hypoxia‐inducible factor 1, dual‐specificity phosphatase 4, IGF 2, and myelin basic protein, and Bndf‐IV P4 methylation, H4 acetylation, K4me3, and binding of RNA polymerase II and USF‐1. It increased HDAC1 binding to Bndf‐IV promoter, and K27me3 and K4me1 | |||
| Choline supplementation attenuated iron deficiency induced decreases in hippocampal Bndf protein levels, and binding of USF1 to Bndf‐IV promoter of male offsprings | |||
| Choline reversed iron deficiency induced increase in K27me3 and HDAC1, and decrease in K4me3 in promoter of Bndf‐IV of male offsprings | |||
| Choline supplementation reversed iron deficiency induced alterations in hippocampal expression of multiple genes, including those involved in the molecular networks related to autism and schizophrenia | |||
| Rat | Maternal iron deficiency starting 2 weeks before pregnancy, on day 1, on day 7 or on day 14 of gestation (2–6 mg Fe g−1 diet against the normal 1000 mg Fe g−1 diet) | Reduced offsprings' body weight, serum iron, hemoglobin and core body, temperature, and delayed auditory brain stem responses | |
| Rat | Maternal Iron restriction starting 1 week before pregnancy and during gestation (3 mg kg−1 against the normal 150 mg kg−1) | Decreased hemoglobin, red blood cell count, hematocrit, and mean RBC volume compared with controls | |
| Lower body weight at birth and at 3 months of age | |||
| Elevated systolic blood pressure at 3 months, but improved glucose tolerance | |||
| Lower fasting serum triglyceride | |||
| Rat | Maternal Iron restriction for 4 weeks prior to and during pregnancy (7.5 mg kg−1 against the normal 50 mg kg−1) | Gestation day 13 male rat embryo showed significant upregulation of 979 genes and downregulation of 1545 genes involved in processes associated with the initiation of mitosis, BAD‐mediated apoptosis, the assembly of RNA polymerase II preinitiation complexes and WNT signaling | |
| Upregulation of 7 proteins and downregulation of 10 proteins involved in cell proliferation, protein transport and folding, cytoskeletal remodeling and the proteasome complex | |||
| Mice | Maternal alcohol on gestational day 9 of pregnancy (5.8 g kg−1 ethanol) with or without methyl supplementation (15 g Choline, 15 g Betaine, 15 mg Folic Acid, 1.5 mg Vitamin B12, 7.5 g | Methyl supplementation attenuated alcohol induced decreases in embryonic IGF2 promoter methylation and IGF 2 expression, and decreased mortality, and digit and vertebral malformations | |
| Zinc | Rat | Maternal zinc restriction 2 weeks before and during pregnancy (10 mg kg−1 diet against the normal 35 mg kg−1) | Lower offspring weight at birth, weaning and 6 months of age |
| Increased body fat, and decreased lean mass, fat‐free mass and fasting plasma insulin levels at 6 months of age | |||
| Lower total cholesterol at 6 months | |||
| Mice | Maternal zinc restriction (5.0 µg Zn g−1 against the normal 35 µg Zn g−1) from gestation day 8 until delivery, cadmium administration to offsprings at 5 weeks (5 mg kg−1) | Increased hepatic MT2 mRNA at 5 weeks | |
| Altered histone modifications in the MT2 promoter on day 1 and at 5 weeks | |||
| Prolonged MTF1 binding to the MT2 promoter region at 5 weeks | |||
| Mice | Maternal zinc restriction from gestation day 7 to birth | Immunodeficiency in F1–F3 offsprings | |
| Mice | Maternal zinc restriction (8 ppm against the normal 30 ppm) during pregnancy | Increased systolic blood pressure and decreased glomerular filtration rate associated with a reduction in the number and size of nephrons. Activation of renal apoptosis, reduction in catalase activity, glutathione peroxidase activity, and glutathione levels and increased fibrosis and lipid peroxidation end products | |
| Mice | Maternal preconception (3–5 d) zinc restriction (<1 mg kg−1 against the normal 29 mg kg−1) | Decreased histone H3K4 trimethylation and global DNA methylation in zinc deficient oocytes, with 3–20 fold increase in transcript abundance of repetitive elements (Iap, Line1, Sineb1, Sineb2), and a decrease in Gdf9, Zp3 and Figla mRNA | |
| Only 53% (3 d) and 8% (5 d) of zinc deficient mature eggs reached the 2‐cell stage after IVF | |||
| In vivo fertilized 2‐cell embryos cultured in vitro formed fewer (38%) blastocysts compared to control embryos (74%) | |||
| Decreased Igf2 and H19 mRNA in zinc deficient blastocyst | |||
| Magnesium | Rat | Maternal magnesium restriction (0.003% against the normal 0.082% magnesium) | Higher hepatic 11β‐hydroxysteroid dehydrogenase‐2 (Hsd11b2) promoter methylation |
Effects and/or alterations are those reported in F1 generation due to exposure in F0 in comparison to the control group without the exposure, except otherwise stated. DMR: differentially methylated region; RBC: red blood cells.
Selected studies highlighting noncompliance to healthy recommendations during pregnancy in different countries
| Healthy recommendation [reference] | Observations | Location |
|---|---|---|
| Folic acid supplement intake, alcohol consumption, smoking, diet, and physical activity before pregnancy among | Among 238 pregnant women, only 2.9% were taking 400 µg or more of folic acid supplements a day | Southampton, United Kingdom |
| Heavy drinking of four or more units of alcohol a week was common | ||
| 74% of those that became pregnant were smokers | ||
| 53% consumed five or more portions of fruit and vegetables a day | ||
| 57% of those who became pregnant had taken any strenuous exercise in the past three months | ||
| Supplementation of 400 µg folic acid daily during the periconceptional period, and exercise recommendation (≥3.5 h a week) by the Danish Health and Medicines Authority | Among 22 000 pregnant women, only 22.3% who had planned their pregnancy (13 952) fully complied with the recommendation, while only 13.6% of the overall 22 000 women complied | Copenhagen, Denmark |
| Among 7915 pregnant women, only 38% met the recommendation for exercise in early pregnancy | ||
| Dietary iron supplementation during pregnancy | Among 308 pregnant women, 49.7% used iron supplements continuously during the second and third trimesters of pregnancy, while 38.3% reported partial use and 12.0% used no iron supplements | Riyadh, Saudi Arabia |
| Alcohol intake recommendations during pregnancy | Among 837 and 1248 women, 72 and 80% consumed alcohol during pregnancy | Australia |
| Intermittent presumptive treatment and use of insecticide treated nets during pregnancy | Among 720 pregnant women, 51.6 and 25.9% received the first and second doses of intermittent presumptive treatment, respectively, while 41% slept under insecticide treated nets although only 15.4% used it correctly | Enugu, Nigeria |
| Dietary behaviors, physical activity, and smoking recommendations | Among 1231 pregnant women in the Latina Gestational Diabetes Mellitus Study, 13% met physical activity guidelines, 19% met fruit/vegetable guidelines, 21% of women smoked, and 1.4% consumed alcohol during pregnancy | Massachusetts, USA |
| Smoking during pregnancy | The overall prevalence of smoking before pregnancy was 24.7% in 2010, and 12.3% during pregnancy in 11 states of the USA (Alaska, Arkansas, Colorado, Hawaii, Maine, Nebraska, Oklahoma, Utah, Washington, and West Virginia). The prevalence after delivery was 17.2% in 2010 | 11 states of the USA |
| Smoking During pregnancy | Among 369 547 pregnant women in Canada, 23% were smokers in 2009–2010, with higher prevalence in the Northern territories (59.3%) | Canada |
| Perinatal alcohol consumption | Among 1594 pregnant women, 84% had consumed alcohol the year prior to pregnancy (14% considered hazardous consumption) and 6% at least once during pregnancy | Sweden |
| Perinatal alcohol consumption | Among 1303 pregnant women, two‐thirds and half in the first trimester consumed alcohol over the Department of Health (UK) guidelines of ≤2 units per week before pregnancy | Leeds, UK |
The observations made from these studies shows that noncompliance to healthy recommendations during pregnancy is not limited to low and middle income countries but that even women in the developed countries mostly do not adhere to those recommendations that will ensure healthy growth of their fetus.
World Health Organization recommended dietary allowances (RDA) of micronutrients during pregnancy
| Nutrient supplementation [reference] | RDA |
|---|---|
| Folic acid | 400 µg of folic acid throughout pregnancy for prevention of neural tube defects, congenital birth defects and possibly risk of adult chronic disease |
| Iron | 30–60 mg of elemental iron throughout pregnancy for prevention of anemia |
| Vitamin A | Up to 10 000 IU vitamin A (daily dose) OR Up to 25 000 IU vitamin A (weekly dose) for a minimum of 12 weeks during pregnancy until delivery where deficiency is a public health problem for prevention of night blindness |
| Vitamin D | Insufficient evidence for recommendation |
| Iodine | 250 µg d−1 of iodine supplement or 400 mg per year of iodized oil supplement during pregnancy in countries where less than 20% of households have access to iodized salt |
| Calcium | 1.5–2.0 g from 20 weeks of gestation to end of pregnancy in areas where calcium intake is low for prevention of preeclampsia |
Some changes introduced by food processing techniques
| Beneficial change | Harmful change |
|---|---|
| Increased bioavailability of bioactive compounds due to better release from food matrix, e.g., during cooking | Introduction of trans fatty acids during preparation of fast foods and other commercial junk foods |
| Improvement of antioxidant properties of naturally occurring compounds, e.g., oxidation of polyphenols during storage increasing their bioactivity | Removal of bioactive‐rich bran layer (including minerals, vitamins and other functional compounds) of grains during polishing |
| Formation of novel compounds having antioxidant activity (i.e., Maillard reaction products) | Loss of naturally occurring antioxidants, e.g., ascorbic acid during cooking and pasteurization of fruits and vegetables |
| Increased bioactivity due to synergistic action of compounds from different sources in a single product | Formation of novel compounds having prooxidant activity (i.e., Maillard reaction products) |
| Interactions among different compounds mixed in a single product(e.g., lipids and natural antioxidants, lipids and Maillard reaction products) | |
| Decreased bioactivity due to competitive inhibition of beneficial action when compounds from different sources are mixed in a single product |
Source: Refs. 217, 218, 219, 220.
Figure 1Proposed cumulative effects of epigenetic influences and environmental factors on the chronic disease risk profiles. NCCDs: non‐cmmunicable chronic diseases; SSBs: sugar sweetened beverages.